000			02254 a2200637 4500
005			20250516111821.0
264		0	_c20121121
008			201211s 0 0 eng d
022			_a1099-1069
024	7		_a10.1002/hon.1012 _2doi
040			_aNLM _beng _cNLM
100	1		_aYang, Bo
245	0	0	_aRepeated transfusions of autologous cytokine-induced killer cells for treatment of haematological malignancies in elderly patients: a pilot clinical trial. _h[electronic resource]
260			_bHematological oncology _cSep 2012
300			_a115-22 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBiomarkers, Tumor
650	0	4	_aCells, Cultured _xdrug effects
650	0	4	_aComorbidity
650	0	4	_aCytokine-Induced Killer Cells _xtransplantation
650	0	4	_aFemale
650	0	4	_aHematologic Neoplasms _xdrug therapy
650	0	4	_aHumans
650	0	4	_aImmunotherapy, Adoptive
650	0	4	_aInterferon-gamma _xpharmacology
650	0	4	_aInterleukin-2 _xpharmacology
650	0	4	_aL-Lactate Dehydrogenase _xblood
650	0	4	_aLeukemia, Lymphocytic, Chronic, B-Cell _xdrug therapy
650	0	4	_aLymphoma, Non-Hodgkin _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMultiple Myeloma _xdrug therapy
650	0	4	_aMyelodysplastic Syndromes _xdrug therapy
650	0	4	_aPilot Projects
650	0	4	_aRecombinant Proteins _xpharmacology
650	0	4	_aRemission Induction
650	0	4	_aSalvage Therapy
650	0	4	_aThymopentin _xpharmacology
650	0	4	_aTreatment Outcome
650	0	4	_abeta 2-Microglobulin _xanalysis
700	1		_aLu, Xue-chun
700	1		_aYu, Rui-li
700	1		_aChi, Xiao-hua
700	1		_aLiu, Yang
700	1		_aWang, Yao
700	1		_aDai, Han-ren
700	1		_aZhu, Hong-li
700	1		_aCai, Li-li
700	1		_aHan, Wei-dong
773	0		_tHematological oncology _gvol. 30 _gno. 3 _gp. 115-22
856	4	0	_uhttps://doi.org/10.1002/hon.1012 _zAvailable from publisher's website
999			_c22099873 _d22099873